Zobrazeno 1 - 10
of 402
pro vyhledávání: '"Abbas, Ardehali"'
Autor:
Jenny Y. Chen, MD, Rongzi Shan, MD, Stephanie Fraschilla, RN, MSN, CCTC, Melissa Moore, RN, BSN, CCTC, Jeffrey J. Hsu, MD, PhD, Negeen Shahandeh, MD, Abbas Ardehali, MD, Ali Nsair, MD, Rushi V. Parikh, MD
Publikováno v:
JHLT Open, Vol 5, Iss , Pp 100120- (2024)
The COVID-19 pandemic led to changes in heart transplantation, including transitioning from in-person to virtual selection committee meetings. The longer-term impact of this transition on committee perceptions and patient selection outcomes has not b
Externí odkaz:
https://doaj.org/article/fc5e169aeb99487aaab6b347fdbf5806
Safety and efficacy of delaying lung transplant surgery to a morning startCentral MessagePerspective
Autor:
Samuel T. Kim, BA, Yu Xia, MD, MS, Peter D. Cho, BS, Jonathan K. Ho, MD, Swati Patel, MD, Christine Lee, RN, Abbas Ardehali, MD
Publikováno v:
JTCVS Open, Vol 16, Iss , Pp 1008-1017 (2023)
Objective: We aimed to evaluate the safety and efficacy of delaying lung transplantation until morning for donors with cross-clamp times occurring after 1:30 am. Methods: All consented adult lung transplant recipients between March 2018 and May 2022
Externí odkaz:
https://doaj.org/article/e3ca1281104f440cbce99205cd855f75
Autor:
Yu Xia, MD, MS, Samuel T. Kim, BA, Peter D. Cho, BS, Michael J. Dacey, MD, Eric Buch, MD, Jonathan K. Ho, MD, Abbas Ardehali, MD
Publikováno v:
Transplantation Direct, Vol 10, Iss 3, p e1580 (2024)
Background. Lung transplant surgery creates surgical pulmonary vein isolation (PVI) as a routine part of the procedure. However, many patients with pretransplant atrial fibrillation continue to have atrial fibrillation at 1 y. We hypothesized that th
Externí odkaz:
https://doaj.org/article/bf490ce2815a4d228c00e18c8ea77604
Autor:
Abbas Ardehali
Unique in the field of cardiac surgery, Khonsari's Cardiac Surgery: Safeguards and Pitfalls in Operative Technique details the most important techniques in a concise, readable, and richly illustrated format, with a focus on avoiding and managing surg
Autor:
Daniel R. Calabrese, Tasha Tsao, Mélia Magnen, Colin Valet, Ying Gao, Beñat Mallavia, Jennifer J. Tian, Emily A. Aminian, Kristin M. Wang, Avishai Shemesh, Elman B. Punzalan, Aartik Sarma, Carolyn S. Calfee, Stephanie A. Christenson, Charles R. Langelier, Steven R. Hays, Jeffrey A. Golden, Lorriana E. Leard, Mary Ellen Kleinhenz, Nicholas A. Kolaitis, Rupal Shah, Aida Venado, Lewis L. Lanier, John R. Greenland, David M. Sayah, Abbas Ardehali, Jasleen Kukreja, S. Samuel Weigt, John A. Belperio, Jonathan P. Singer, Mark R. Looney
Publikováno v:
JCI Insight, Vol 7, Iss 24 (2022)
Clinical outcomes after lung transplantation, a life-saving therapy for patients with end-stage lung diseases, are limited by primary graft dysfunction (PGD). PGD is an early form of acute lung injury with no specific pharmacologic therapies. Here, w
Externí odkaz:
https://doaj.org/article/1ce137fa246e4f4d9647ad53ba99ced1
Autor:
Mohammad Teshnisi, Farveh Vakilian, Nahid Zirak, Alireza Sedaghat, Seyed Hoseini Khah, Amir Mohammadpoor, Vahab Azmonfar, Farideh Keshtan, Masoumeh Rohani, Reza Bagheri, Abbas Ardehali
Publikováno v:
Polish Journal of Thoracic and Cardiovascular Surgery, Vol 17, Iss 1, Pp 33-38 (2020)
Externí odkaz:
https://doaj.org/article/d386558bbf9842cca4097b0ea6a3bad6
Autor:
Rongzi Shan, Neha V Chandra, Jeffrey J Hsu, Stephanie Fraschilla, Melissa Moore, Abbas Ardehali, Ali Nsair, Rushi V Parikh
Publikováno v:
JMIR Cardio, Vol 6, Iss 1, p e35490 (2022)
BackgroundHeart transplant selection committee meetings have transitioned from in-person to remote video meetings during the COVID-19 pandemic, but how this impacts committee members and patient outcomes is unknown. ObjectiveThe aim of this study is
Externí odkaz:
https://doaj.org/article/97a3eb4401d0487db581ae3bfd0dbdda
Autor:
Anna-Maria Hoffmann-Vold, S. Samuel Weigt, Rajan Saggar, Vyacheslav Palchevskiy, Elizabeth R. Volkmann, Lloyd L. Liang, David Ross, Abbas Ardehali, Joseph P. Lynch, III, John A. Belperio
Publikováno v:
EBioMedicine, Vol 50, Iss , Pp 379-386 (2019)
Background: Some interstitial lung disease (ILD) patients develop a progressive fibrosing-ILD phenotype (PF-ILD), with similar persistent lung function decline suggesting common molecular pathways involved. Nintedanib, a tyrosine kinase inhibitor tar
Externí odkaz:
https://doaj.org/article/acead5a69b63476e8d773a006e546600
Autor:
Gregoire Ruffenach, Soban Umar, Mylene Vaillancourt, Jason Hong, Nancy Cao, Shervin Sarji, Shayan Moazeni, Christine M Cunningham, Abbas Ardehali, Srinivasa T Reddy, Rajan Saggar, Gregory Fishbein, Mansoureh Eghbali
Publikováno v:
EMBO Molecular Medicine, Vol 11, Iss 9, Pp 1-19 (2019)
Abstract Pulmonary hypertension secondary to pulmonary fibrosis (PF‐PH) is one of the most common causes of PH, and there is no approved therapy. The molecular signature of PF‐PH and underlying mechanism of why pulmonary hypertension (PH) develop
Externí odkaz:
https://doaj.org/article/e06b37c3ad3342498cbb6d5a007c42db
Autor:
Ashley Hu, Ashley Prosper, Kathleen Ruchalski, Christian Fulinara, Alina Huynh, David Sayah, Stephen S. Weigt, Jonathan Singer, Abbas Ardehali, Reshma Biniwale, Deena Goldwater, Joanna Schaenman
Publikováno v:
Annals of Thoracic Surgery Short Reports. 1:174-178
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28bc21b819b72a1f18c0dd2d04c52dc3
https://doi.org/10.1016/j.atssr.2022.11.005
https://doi.org/10.1016/j.atssr.2022.11.005